- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01137461
Efficacy of Embryo Transfer Procedure Guided by Transvaginal Ultrasound Versus Abdominal Ultrasound in Oocytes Recipients
April 13, 2011 updated by: Fundació Privada Eugin
Evaluation of Efficacy of Embryo Transfer Procedure Guided by Transvaginal Ultrasound Versus Abdominal Ultrasound in Recipients of Oocytes. A Single-centre, Randomized Clinical Trial.
The objective of this study is to evaluate the efficacy of embryo transfer procedure guided by transvaginal ultrasound versus abdominal ultrasound in recipients of oocytes as well as the advantages and disadvantages of the new technique.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
330
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Barcelona, Spain, 08029
- Clinica EUGIN
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Oocyte recipients.
- Uterus without previously detected anomalies.
- Patients able to understand the study requirements who want to participate during all its duration and that have signed the informed consent.
Exclusion Criteria:
- Turner syndrome, Black race (significantly lower implantational rates)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: abdominal ultrasound
traditional technique
|
Embryo transfer in oocyte recipients
|
|
Other: transvaginal ultrasound
new technique
|
Embryo transfer in oocyte recipients
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Clinical pregnancy rate
Time Frame: 40 days after embryo transfer
|
Evidence of gestational sac by transvaginal ultrasound
|
40 days after embryo transfer
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Daniel Bodri, Clinica EUGIN
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2010
Primary Completion (Actual)
October 1, 2010
Study Completion (Actual)
October 1, 2010
Study Registration Dates
First Submitted
June 3, 2010
First Submitted That Met QC Criteria
June 3, 2010
First Posted (Estimate)
June 4, 2010
Study Record Updates
Last Update Posted (Estimate)
April 14, 2011
Last Update Submitted That Met QC Criteria
April 13, 2011
Last Verified
April 1, 2011
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- TATV
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infertility
-
Assuta Hospital SystemsMaccabi Healthcare Services, IsraelCompletedInfertility, Female Infertility, Male InfertilityIsrael
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedPregnancy | Male Infertility | Female InfertilityNetherlands
-
Sapientiae InstituteTerminated
-
Esraa Gamal AhmedAin Shams Maternity HospitalUnknownUnexplained Female Infertility
-
Gazi UniversityCompletedMale Infertility | Unexplained Infertility
-
King's College LondonNot yet recruitingInfertility | Infertility, Female | Infertility Unexplained | Infertility of Tubal Origin
-
Wake Forest University Health SciencesWithdrawnUterine Diseases | Endometriosis | Infertility Unexplained | Endometrial Diseases | Infertility; Female, NonimplantationUnited States
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMale Infertility, AzoospermiaUnited States
-
Pacific Fertility CenterTerminatedPrimary Female Infertility | Secondary Female Infertility
-
Yuzuncu Yil UniversityCompletedUnexplained Infertility | Female Infertility | Anovulatory InfertilityTurkey (Türkiye)
Clinical Trials on ultrasound-guided embryo transfer
-
Kasr El Aini HospitalCompleted
-
The University of Hong KongThe University of New South WalesCompleted
-
IVI MadridTerminated
-
The University of Hong KongPeking University Third Hospital; Nanfang Hospital of Southern Medical University and other collaboratorsTerminated
-
Cairo UniversityRecruiting
-
University Hospital Virgen de las NievesInstituto de Salud Carlos IIICompletedInfertility | Pregnancy, MultipleSpain
-
Stanford UniversityCompleted
-
National Research Centre, EgyptNot yet recruiting
-
IgenomixUnknown
-
The First Affiliated Hospital with Nanjing Medical...The First Affiliated Hospital of Anhui Medical University; RenJi Hospital; The... and other collaboratorsCompleted